[Federal Register Volume 65, Number 229 (Tuesday, November 28, 2000)]
[Notices]
[Page 70939]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-30296]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated September 6, 2000, and published in the Federal 
Register on September 25, 2000 (65 FR 57623), Roche Diagnostics 
Corporation, 9115 Hague Road, Indianapolis, Indiana 46250, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as an importer of alphamethadol (9605), a basic class of 
controlled substance listed in Schedule I.
    The firm plans to import the alphamethadol to manufacture 
diagnostic products for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in title 21, United States Code, Section 823(a) and 
determined that the registration of Roche Diagnostics Corporation to 
import alphamethadol is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Roche Diagnostics Corporation on a regular basis to ensure that the 
company's continued registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, audits of the company's 
records, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to section 1008(a) of the Controlled Substances Import and 
Export Act and in accordance with title 21, Code of Federal 
Regulations, section 1301.34, the above firm is granted registration as 
an exporter of the basic class of controlled substance listed above.

    Dated: November 8, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-30296 Filed 11-27-00; 8:45 am]
BILLING CODE 4410-09-M